https://www.canada.ca/en/patented-medicine-prices-review/services/voluntary-compliance-undertakings/vcu-patanol-pataday.html
Voluntary compliance undertaking of Novartis Pharmaceuticals Canada Inc. to the Patented Medicine...
voluntary compliancenovartis pharmaceuticals
https://www.novartis.com/us-en/about/novartis-us
Novartis Pharmaceuticals in the U.S. | Novartis U.S.
Learn how Novartis is reimagining medicine in the US to improve the lives of patients and healthcare professionals and empowering them when facing serious...
novartis pharmaceuticalsin the
https://www.law360.com/healthcare-authority/cases/69bdaeb49269405eecb48840?article_sidebar=1
P.M. v. NOVARTIS PHARMACEUTICALS CORPORATION
Parties, docket activity and news coverage of federal case P.M. v. NOVARTIS PHARMACEUTICALS CORPORATION, case number 2:26-cv-02917, from New Jersey Court.
p mnovartis pharmaceuticalscorporation
https://www.law360.com/cases/4ebbfc9b5157d433b5000001
Novartis Pharmaceuticals Corporation et al v. Watson Laboratories Inc. et al
Parties, docket activity and news coverage of federal case Novartis Pharmaceuticals Corporation et al v. Watson Laboratories Inc. et al, case number...
novartis pharmaceuticalscorporationetwatsonlaboratories
https://www.uschamber.com/cases/discrimination/novartis-pharmaceuticals-corporation-v-lopes-et-al
Novartis Pharmaceuticals Corporation v. Lopes, et al. | U.S. Chamber of Commerce
Supreme Court declines to review overtime exemptions under Fair Labor Standards Act
novartis pharmaceuticals
https://www.calcalistech.com/ctech/articles/0,7340,L-3752698,00.html
Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals - CTech
Dec 24, 2018 - The investment is part of a licensing option agreement signed between the two companies
10 millionanti cancernovartisinvests
https://www.bluewin.ch/en/news/novartis-announces-billion-euro-investments-in-the-usa-2648202.html
Pharmaceuticals: Novartis announces billion-euro investments in the USA | blue News
The pharmaceutical company Novartis plans to invest a total of 23 billion dollars in the USA over the next five years to expand production and research. This...
in the usapharmaceuticalsnovartisannouncesbillion
https://www.prnewswire.com/news-releases/costim-pharmaceuticals-inc-acquired-by-novartis-245809091.html
CoStim Pharmaceuticals, Inc. Acquired by Novartis
/PRNewswire/ -- MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. ("CoStim") has been acquired by Novartis...
pharmaceuticalsincacquirednovartis
https://www.novartis.com/news/media-releases/novartis-deepens-its-industry-leading-pipeline-acquisition-spinifex-pharmaceuticals-inc
Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc. |...
its industry